T. Naas, P. Bogaerts, C. Bauraing, Yves Degheldre, Y. Glupczynski, P. Nordmann (2006)
Emergence of PER and VEB extended-spectrum beta-lactamases in Acinetobacter baumannii in Belgium.The Journal of antimicrobial chemotherapy, 58 1
J. Turton, M. Ward, N. Woodford, M. Kaufmann, R. Pike, D. Livermore, T. Pitt (2006)
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii.FEMS microbiology letters, 258 1
J. Coelho, N. Woodford, M. Afzal-Shah, D. Livermore (2006)
Occurrence of OXA-58-Like Carbapenemases in Acinetobacter spp. Collected over 10 Years in Three ContinentsAntimicrobial Agents and Chemotherapy, 50
G. Talbot, J. Bradley, J. Edwards, D. Gilbert, M. Scheld, J. Bartlett (2006)
Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 42 5
A. Levin (2002)
Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 8 3
L. Dijkshoorn, H. Aucken, P. Gerner-Smidt, P. Janssen, Me Kaufmann, J. Garaizar, J. Ursing, T. Pitt (1996)
Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methodsJournal of Clinical Microbiology, 34
A. Kwa, C. Loh, J. Low, A. Kurup, V. Tam (2005)
Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 41 5
L. Dalla-Costa, J. Coelho, H. Souza, M. Castro, C. Stier, K. Bragagnolo, Á. Réa-Neto, S. Penteado-Filho, D. Livermore, N. Woodford (2003)
Outbreak of Carbapenem-Resistant Acinetobacter baumannii Producing the OXA-23 Enzyme in Curitiba, BrazilJournal of Clinical Microbiology, 41
A. Michalopoulos, S. Tsiodras, Kostas Rellos, S. Mentzelopoulos, M. Falagas, M. Falagas (2005)
Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 11 2
M. Afzal-Shah, N. Woodford, D. Livermore (2001)
Characterization of OXA-25, OXA-26, and OXA-27, Molecular Class D β-Lactamases Associated with Carbapenem Resistance in Clinical Isolates of Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 45
A. Levin, A. Barone, Juliana Penço, M. Santos, I. Marinho, E. Arruda, Edison Manrique, S. Costa (1999)
Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 28 5
Boris Ehrenstein, A. Bernards, L. Dijkshoorn, Peter Gerner-Smidt, K. Towner, Philippe Bouvet, FranzD Daschner, Andhajo Grundmann (1996)
Acinetobacter species identification by using tRNA spacer fingerprintingJournal of Clinical Microbiology, 34
N. Woodford, M. Ellington, J. Coelho, J. Turton, M. Ward, S. Brown, S. Amyes, D. Livermore (2006)
Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.International journal of antimicrobial agents, 27 4
G. Silva, S. Quinteira, E. Bértolo, J. Sousa, L. Gallego, Aida Duarte, L. Peixe (2004)
Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula.The Journal of antimicrobial chemotherapy, 54 1
Mario Vaneechoutte, L. Dijkshoorn, I. Tjernberg, A. Elaichouni, P. Vos, G. Claeys, G. Verschraegen (1995)
Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysisJournal of Clinical Microbiology, 33
C. Héritier, L. Poirel, T. Lambert, P. Nordmann (2005)
Contribution of Acquired Carbapenem-Hydrolyzing Oxacillinases to Carbapenem Resistance in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 49
J. Turton, M. Kaufmann, M. Warner, Juliana Coelho, L. Dijkshoorn, T. Reijden, Tyrone Pitt (2004)
A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England.The Journal of hospital infection, 58 3
H. Dessel, L. Dijkshoorn, T. Reijden, N. Bakker, A. Paauw, P. Broek, J. Verhoef, S. Brisse (2004)
Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals.Research in microbiology, 155 2
J. Coelho, N. Woodford, J. Turton, D. Livermore (2004)
Multiresistant acinetobacter in the UK: how big a threat?The Journal of hospital infection, 58 3
J. Andrews (2005)
BSAC standardized disc susceptibility testing method (version 4).The Journal of antimicrobial chemotherapy, 56 1
D. Livermore (2005)
Tigecycline: what is it, and where should it be used?The Journal of antimicrobial chemotherapy, 56 4
N. Markou, H. Apostolakos, C. Koumoudiou, M. Athanasiou, A. Koutsoukou, I. Alamanos, L. Gregorakos (2003)
Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patientsCritical Care, 7
Helen Donald, W. Scaife, S. Amyes, H. Young (2000)
Sequence Analysis of ARI-1, a Novel OXA β-Lactamase, Responsible for Imipenem Resistance inAcinetobacter baumannii 6B92Antimicrobial Agents and Chemotherapy, 44
J. Li, R. Nation, R. Milne, J. Turnidge, K. Coulthard (2005)
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.International journal of antimicrobial agents, 25 1
C. Héritier, L. Poirel, P. Fournier, J. Claverie, D. Raoult, P. Nordmann (2005)
Characterization of the Naturally Occurring Oxacillinase of Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 49
C. Henwood, Tess Gatward, M. Warner, D. James, M. Stockdale, R. Spence, K. Towner, D. Livermore, N. Woodford (2002)
Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936).The Journal of antimicrobial chemotherapy, 49 3
E. Bergogne-Bérézin, K. Towner (1996)
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological featuresClinical Microbiology Reviews, 9
Journal of Clinical Microbiology – Unpaywall
Published: Oct 1, 2006
Access the full text.
Sign up today, get DeepDyve free for 14 days.